Medicare negotiation bill passes Senate by March 2026

Bipartisan support for drug price reforms will overcome pharmaceutical industry resistance, culminating in a Senate vote by early 2026. Passage is likely due to pressure from both parties on affordability ahead of the 2026 midterms.

Implied probability (Yes)

68%